Benzylimidazolines as h5-HT1B/1D Serotonin Receptor Ligands: A Structure−Affinity Investigation-Reference-Cited by-同舟云学术

Benzylimidazolines as h5-HT1B/1D Serotonin Receptor Ligands: A Structure−Affinity Investigation

Published:1998-05-23 Issue:13 Volume:41 Page:2243-2251
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Law Ho¹,Dukat Malgorzata¹,Teitler Milt¹,Lee David K. H.¹,Mazzocco Lucia¹,Kamboj Raj¹,Rampersad Vik¹,Prisinzano Thomas¹,Glennon Richard A.¹

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia 23298-0540, Department of Pharmacology, Albany Medical College, Albany, New York 12208, and Allelix Biopharmaceuticals, Mississauga, Ontario L4V 1V7, Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm970513p

Reference45 articles.

1. Molecular biology of 5-HT receptors

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical sympathomimetic drug lerimazoline mediates contractile effects in rat aorta predominantly by 5-HT2A receptors;Bosnian Journal of Basic Medical Sciences;2017-06-19

2. Elucidation of the profound antagonism of contractile action of phenylephrine in rat aorta effected by an atypical sympathomimetic decongestant;The Korean Journal of Physiology & Pharmacology;2017

3. 7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A1 and A2A adenosine receptors. Molecular modeling and pharmacological studies;European Journal of Medicinal Chemistry;2014-09

4. Discovery of 2-[3,5-Dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl]-3,5-dioxo-2,3,4,5-tetrahydro[1,2,4]triazine-6-carbonitrile (MGL-3196), a Highly Selective Thyroid Hormone Receptor β Agonist in Clinical Trials for the Treatment of Dyslipidemia;Journal of Medicinal Chemistry;2014-04-08

5. Novel Drug OMS103HP Reduces Pain and Improves Joint Motion and Function for 90 Days After Arthroscopic Meniscectomy;Arthroscopy: The Journal of Arthroscopic & Related Surgery;2011-08